As a second step of validation, a multivariable model was applied and significantly longer LTLs could be demonstrated in the active treatment group also after adjusting for sex, age, smoking, hypertension, diabetes, IHD, CRP, NYHA class III and LTL at inclusion (p = 0.03) (Supplementary Table S2). This evidence concerns the gene CRP and Hypertension.